Description
Phase
N/AInclusion and Exclusion Criteria
Please contact the trial administrator to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- So Cal Diabetes, Torrance, California, 90505
- AMCR Institute, Escondido, California, 92026
-
Oregon
- Oregon Health & Science University, Portland, Oregon, 97239
-
Colorado
- Barbara Davis Center, Aurora, Colorado, 80045
- Barbara Davis Center, Aurora, Colorado, 80045
-
Washington
- Tri-Cities Diabetes and Endocrinology Center, Richland, Washington, 99352
-
Oklahoma
- Pediatric Endocrinology, Genetics & Metabolism, Oklahoma City, Oklahoma, 73112
-
Texas
- Diabetes and Glandular Disease Clinic, San Antonio, Texas, 78229
- Consano Clinical Research, LLC, San Antonio, Texas, 78258
- Northeast Clinical Research of San Antonio, LLC, Schertz, Texas, 78154
- Endocrine Associates, Houston, Texas, 77004
-
Nebraska
- Complete Endocrinology, Lincoln, Nebraska, 68506
-
Arkansas
- Medical Investigations, Inc., Little Rock, Arkansas, 72205
-
Louisiana
- Imperial Health, Lake Charles, Louisiana, 70601
-
Minnesota
- International Diabetes Center, Minneapolis, Minnesota, 55416
-
Tennessee
- AM Diabetes and Endocrinology Center, Bartlett, Tennessee, 38133
- University Diabetes and Endocrine Consultants, Chattanooga, Tennessee, 37411
-
Indiana
- Good Samaritan Hospital Physician Services, Vincennes, Indiana, 47591
- Isaiah Pittman IV, MD, Terre Haute, Indiana, 47802
-
Georgia
- East Alabama Endocrinology PC, Columbus, Georgia, 31907
- Atlanta Diabetes Associates, Atlanta, Georgia, 30318
- Pediatric Endocrine Associates, P.C., Atlanta, Georgia, 30342
- Endocrine Research Solutions, Roswell, Georgia, 30076
Powered by
SC CTSI